Approaches and challenges in SARS-CoV-2 vaccine development

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorDagotto, Gabriel-
Autor(es): dc.creatorYu, Jingyou-
Autor(es): dc.creatorBarouch, Dan H.-
Data de aceite: dc.date.accessioned2026-02-09T11:29:14Z-
Data de disponibilização: dc.date.available2026-02-09T11:29:14Z-
Data de envio: dc.date.issued2020-09-22-
Data de envio: dc.date.issued2020-09-22-
Data de envio: dc.date.issued2020-09-
Fonte completa do material: dc.identifierhttps://repositorio.ufla.br/handle/1/43154-
Fonte completa do material: dc.identifierhttps://www.sciencedirect.com/science/article/pii/S1931312820304558-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/1141804-
Descrição: dc.descriptionThe explosive spread of SARS-CoV-2 suggests that a vaccine will be required to end this global pandemic. Progress in SARS-CoV-2 vaccine development to date has been faster than for any other pathogen in history. Multiple SARS-CoV-2 vaccine candidates have been evaluated in preclinical models and are currently in clinical trials. In this Perspective, we discuss three topics that are critical for SARS-CoV-2 vaccine development: antigen selection and engineering, preclinical challenge studies in non-human primate models, and immune correlates of protection.-
Idioma: dc.languageen-
Publicador: dc.publisherCell Press-
Direitos: dc.rightsrestrictAccess-
???dc.source???: dc.sourceCell Host & Microbe-
Palavras-chave: dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-
Palavras-chave: dc.subjectCOVID-19 - Vaccine-
Título: dc.titleApproaches and challenges in SARS-CoV-2 vaccine development-
Tipo de arquivo: dc.typeArtigo-
Aparece nas coleções:Repositório Institucional da Universidade Federal de Lavras (RIUFLA)

Não existem arquivos associados a este item.